DNL343 and disease progression in amyotrophic lateral sclerosis: A randomized clinical trial

Authors

• Sabrina Paganoni, Harvard University
• Timothy Miller, Washington University School of Medicine in St. Louis
• et al.

Journal

JAMA Network Open

Publication Date

9-1-2026

Volume

9

Issue

9

First Page

e2634809

Document Type

Open Access Publication

DOI

10.1001/jamanetworkopen.2026.34809

Rights and Permissions

Paganoni S, Chibnik LB, Quintana M, et al. DNL343 and Disease Progression in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial. JAMA Netw Open. 2026;9(9):e2634809. doi:10.1001/jamanetworkopen.2026.34809. This is an open access article distributed under the terms of the CC-BY-NC-ND License, which does not permit alteration or commercial use, including those for text and data mining, AI training, and similar technologies. © 2026 Paganoni S et al. JAMA Network Open.

Recommended Citation

Paganoni, Sabrina; Miller, Timothy; and et al., "DNL343 and disease progression in amyotrophic lateral sclerosis: A randomized clinical trial." JAMA Network Open. 9, 9. e2634809 (2026).
https://digitalcommons.wustl.edu/oa_4/7663

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.